Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data

被引：0
|
作者：
Tarhini, Ahmad A.
Tan, Aik Choon
Xie, Mengyu
El Naqa, Issam
Saghand, Payman Ghasemi
Dai, Donghai
Chen, James Lin
Ratan, Aakrosh
McCarter, Martin
Carpten, John D.
Colman, Howard
Ikeguchi, Alexandra
Tripathi, Abhishek
Puzanov, Igor
Arnold, Susanne M.
Churchman, Michelle L.
Hwu, Patrick
Conejo-Garcia, Jose
Dalton, William S.
Weiner, George J.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, l, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA USA
[4] Ohio State Univ, Columbus, OH USA
[5] Univ Virginia, Charlottesville, VA USA
[6] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA
[7] Univ Southern Calif, Los Angeles, CA USA
[8] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[9] Univ Oklahoma, Oklahoma City, OK USA
[10] Univ Oklahoma, Stephenson Canc Ctr, Hlth Sci Ctr, Oklahoma City, OK USA
[11] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[12] Univ Kentucky, Lexington, KY USA
[13] M2Gen, Tampa, FL USA
[14] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2618
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors
    Eljilany, Islam
    Saghand, Payman Ghasemi
    Chen, James
    Ratan, Aakrosh
    McCarter, Martin
    Carpten, John
    Colman, Howard
    Ikeguchi, Alexandra P.
    Puzanov, Igor
    Arnold, Susanne
    Churchman, Michelle
    Hwu, Patrick
    Conejo-Garcia, Jose
    Dalton, William S.
    Weiner, George J.
    El Naqa, Issam M.
    Tarhini, Ahmad A.
    CANCERS, 2023, 15 (20)
  • [2] Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies
    Kazuyuki Mizuno
    Takanori Ito
    Masatoshi Ishigami
    Yoji Ishizu
    Teiji Kuzuya
    Takashi Honda
    Hiroki Kawashima
    Yosuke Inukai
    Hidenori Toyoda
    Kenji Yokota
    Tetsunari Hase
    Osamu Maeda
    Hitoshi Kiyoi
    Masato Nagino
    Hideharu Hibi
    Yasuhiro Kodera
    Yasushi Fujimoto
    Michihiko Sone
    Momokazu Gotoh
    Yuichi Ando
    Masashi Akiyama
    Yoshinori Hasegawa
    Mitsuhiro Fujishiro
    Journal of Gastroenterology, 2020, 55 : 653 - 661
  • [3] Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies
    Mizuno, Kazuyuki
    Ito, Takanori
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Kawashima, Hiroki
    Inukai, Yosuke
    Toyoda, Hidenori
    Yokota, Kenji
    Hase, Tetsunari
    Maeda, Osamu
    Kiyoi, Hitoshi
    Nagino, Masato
    Hibi, Hideharu
    Kodera, Yasuhiro
    Fujimoto, Yasushi
    Sone, Michihiko
    Gotoh, Momokazu
    Ando, Yuichi
    Akiyama, Masashi
    Hasegawa, Yoshinori
    Fujishiro, Mitsuhiro
    JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 653 - 661
  • [4] Real-world data in the era of immune checkpoint inhibitors
    Narita, Yukiya
    ANNALS OF ONCOLOGY, 2021, 32 : S250 - S250
  • [5] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
    Bol, Kalijn Fredrike
    Ellebaek, Eva
    Hoejberg, Lise
    Bagger, Mette Marie
    Larsen, Mathilde Skaarup
    Klausen, Tobias Wirenfeldt
    Kohler, Ulrich Heide
    Schmidt, Henrik
    Bastholt, Lars
    Kiilgaard, Jens Folke
    Donia, Marco
    Svane, Inge Marie
    CANCERS, 2019, 11 (10)
  • [6] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
  • [7] Utilization of real-world data to assess the effectiveness of immune checkpoint inhibitors (ICIs) in elderly patients with metastatic melanoma
    Ernst, D. S.
    McConkey, H.
    Liu, L.
    Butler, M. O.
    Petrella, T.
    Baetz, T.
    Koneru, R.
    Song, X.
    Cheng, T.
    Smylie, M. G.
    Rajagopal, S.
    Mihalcioiu, C.
    Gwadry-Sridhar, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 553 - 553
  • [8] Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
    La, Jennifer
    Cheng, David
    Brophy, Mary T.
    Do, Nhan V.
    Lee, Jerry S. H.
    Tuck, David
    Fillmore, Nathanael R.
    JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 918 - 928
  • [9] Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Spillane, Susan
    Baxi, Shrujal
    Torres, Aracelis Z.
    Lenis, David
    Freedman, Andrew N.
    Mariotto, Angela B.
    Sharon, Elad
    ONCOLOGIST, 2020, 25 (11) : E1753 - E1762
  • [10] Vitiligo is correlated with clinical benefits in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors (ICI).
    Reinas, Gaston Martin
    Muino, Marcelo
    Abal, Mariana
    Gerardi, Carlos Garcia
    Tognelli, Flavio
    Deza, Ernesto Gil
    Gonzalez, Cesar
    Gonzalez, Liliana D.
    Nunell, Marcelo Andres
    Ordonez, Alba Marin
    Morgenfeld, Eduardo L.
    Rivarola, Edgardo G. J.
    Gercovich, Felipe G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345